Tori Marsh - December 22, 2017
One of the only ways to treat diabetes type 1 and 2 are through insulin injections, like Lantus (insulin glargine), that help to control blood sugar. Unfortunately, doctors consistently report low levels of adherence to insulins, Lantus included. The main reason? The cost.
Lantus is a prime example of an expensive insulin—averaging around $274 per month, it is unaffordable for many. But GoodRx is here to help.
Here is some information on Lantus, and how you can save
Why are insulins, and Lantus, so expensive?
The case of insulin prices is an interesting one. See More
The GoodRx Pharmacist - November 21, 2017
For people who need to take insulin, there are a couple of different types—long-acting, short-acting, rapid-acting, intermediate-acting, etc. That’s a lot of options!
One question I see most often is the difference between rapid-acting and long-acting insulins. So, let’s get into it.
What is rapid-acting insulin?
Rapid-acting, or meal-time insulin, is a type of insulin that’s usually taken before, during, or after a meal to lower your blood sugar levels associated with meals. See More
Dr. Sharon Orrange - March 03, 2016
Comparing long-acting insulins? Newly approved Tresiba may come out ahead. With the exception of NPH insulin (the original long-acting insulin—examples include Humulin N and Novolin N), they are all going to cost you. So, if you are already paying big bucks for your long-acting insulin, here are some things to think about:
What does a long-acting or basal insulin do for me? This is your baseline insulin, the insulin that is secreted to control your sugars when you are not eating (in the fasting state). See More
Elizabeth Davis - November 23, 2015
You can now find and compare diabetes supplies on GoodRx! Do a search now to see prices for glucose test strips and meters, control solution, syringes and lancets, and more.
As you may already know, shopping around online will typically get you a lower price than what you’ll find walking in to your local pharmacy.
The GoodRx Pharmacist - October 23, 2015
The other recent insulin approvals are what I like to call spin-off insulin products. For example, Toujeo has the same type of insulin as Lantus (insulin glargine), but is more concentrated. Humalog U-200 is the same exact product as Humalog U-100 (insulin lispro), but once again, more concentrated. See More
Dr. Sharon Orrange - October 06, 2015
More than 29 million Americans have diabetes. That’s more than 10% of the US—and that number continues to rise. More than 1.7 million adults were diagnosed with diabetes in 2012 alone.
Fortunately, several new medications for diabetes have recently been approved—Toujeo (a new insulin product), Synjardy (a new combination of empagliflozin/metformin) and others. These new drugs provide several benefits such as fewer side effects or foolproof self-dosing with an insulin pen. See More
The GoodRx Pharmacist - May 05, 2015
Did you read our blog on insulin vials and think to yourself, does this apply to my insulin pens too? If so, this post is for you!
With so many different insulin and insulin-like products out there these days it can be hard keep track of how long each of these pens stays good.
Depending on your dose, you may still have insulin left in your pen at the manufacturer-recommended time to throw it away. If this sounds like a familiar situation, know that it is important to throw away your pen regardless of whether you have any leftover. See More
The GoodRx Pharmacist - April 29, 2015
With so many different insulin and insulin-like products out there these days it can be hard to keep track of when your vial should be tossed.
Depending on your dose, you may still have insulin left in your vial by the manufacturer-recommended time to throw it away. If this sounds like a familiar situation, know that it is important to throw away your vial regardless of whether you have any leftover. See More
The GoodRx Pharmacist - March 26, 2015
On February 25, 2015, the FDA approved Toujeo—a long-acting insulin indicated to improve sugar control in adults with type 1 and type 2 diabetes.
When will Toujeo be available?
According to the manufacturer, Sanofi-Aventis, Toujeo will be available at the beginning of the second quarter in 2015.
What is long-acting insulin?
Long-acting insulin can also be referred to as basal insulin. Long-acting insulin lowers blood sugar levels slowly and evenly for up to 24 hours. See More
The GoodRx Pharmacist - July 02, 2014
The delivery method of some drugs may be phased out or changed for a few reasons—sometimes a change might be required, like when CFC inhalers for asthma were found to be bad for the environment and replaced by the environmentally friendly HFA inhalers. Manufacturers may also find a better way to deliver their medication that makes it easier to use, and discontinue the older version.